CARDURION PHARMACEUTICALS, INC.
Profile
Company Names
CARDURION PHARMACEUTICALS, INC.
CARDURION PHARMACEUTICALS, LLC
Addresses
78 BLANCHARD ROAD, SUITE 200, BURLINGTON, MA 01803
ONE LINCOLN STREET, BOSTON, MA 02111
220 BOYLSTON STREET, BOSTON, MA 02116
Phone Numbers
617-996-1433
732-306-6695
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2017
State Incorporated:
GEORGIA
Total Amount Raised:
$431,685,720.00
Number of Funding Rounds:
5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2024-07-10
$260,410,720.00
$260,410,720.00
$0.00
Equity
4
2022-12-16
$17,500,000.00
$17,500,000.00
$0.00
Debt
3
2021-10-19
$128,125,000.00
$128,125,000.00
$0.00
Equity
2
2019-11-05
$10,000,000.00
$10,000,000.00
$0.00
Debt
1
2017-03-20
$15,650,000.00
$22,450,000.00
$6,800,000.00
Debt
People
First Name
Middle Name
Last Name
Titles
Related Companies
KEITH
GOTTESDIENER
DIRECTOR
ADAM
KOPPEL
DIRECTOR
PETER
LAWRENCE
EXECUTIVE OFFICER, DIRECTOR
DANIEL
LYNCH
DIRECTOR
EDWARD
MATHERS
DIRECTOR
RA PHARMACEUTICALS, INC.
| RHYTHM PHARMACEUTICALS, INC.
| SATORI PHARMACEUTICALS INC
| MIRNA THERAPEUTICS, INC.
| RHYTHM HOLDING COMPANY, LLC
| LUMENA PHARMACEUTICALS, INC.
| LUMOS PHARMA, INC.
| AMPLYX PHARMACEUTICALS, INC.
| LIQUIDIA TECHNOLOGIES INC
| INOZYME PHARMA, INC.
| SYNLOGIC, INC.
| AFFINIA THERAPEUTICS INC.
| CODE BIOTHERAPEUTICS, INC.
| TREVI THERAPEUTICS, INC.
| SORRISO PHARMACEUTICALS, INC.
| MBX BIOSCIENCES, INC.
| CARDURION PHARMACEUTICALS, INC.
| BRENIG THERAPEUTICS, INC.
| SENTI BIOSCIENCES, INC.
| SENTI BIOSCIENCES HOLDINGS, INC.
| SENTI HOLDINGS, INC.
| SENTI BIOSCIENCES, INC.
MICHAEL
MENDELSOHN
EXECUTIVE OFFICER, DIRECTOR
KENNETH
NOVACK
DIRECTOR
EVAN
RACHLIN
DIRECTOR
ASCENTA CAPITAL SPV I, L.P.
| ASCENTA CAPITAL PROJECT TURING SPV, L.P.
| ASCENTA CAPITAL PROJECT ARGOS SPV, L.P.
| IAMBIC THERAPEUTICS, INC.
| ASCENTA CAPITAL FUND I, L.P.
| CARDURION PHARMACEUTICALS, INC.
| ASCENTA CAPITAL PROJECT IKIGAI SPV, L.P.
| ORSOBIO, INC.
| ASCENTA CAPITAL PROJECT HENRI SPV, L.P.
EMMA
REEVE
DIRECTOR
AMY
SCHULMAN
DIRECTOR
ARSANIS, INC.
| SUONO BIO, INC.
| QUENTIS THERAPEUTICS, INC.
| GLYMPSE BIO, INC.
| CYCLERION THERAPEUTICS, INC.
| CARDURION PHARMACEUTICALS, INC.
| FRACTYL LABORATORIES INC.
| AMAGMA, INC.
| BYHEART, INC.
| QURALIS CORP
| FRACTYL HEALTH, INC.
| LYNDRA THERAPEUTICS, INC.
| THIRTY MADISON, INC.
| VOLASTRA THERAPEUTICS, INC.
| POLARIS PARTNERS X, L.P.
| SEQUELAE, INC.
| NOETIK INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date

